AU2002365205A1 - Brucellosis vaccine composition comprising poly($g(e)-caprolactone) microparticles as an adjuvant - Google Patents

Brucellosis vaccine composition comprising poly($g(e)-caprolactone) microparticles as an adjuvant

Info

Publication number
AU2002365205A1
AU2002365205A1 AU2002365205A AU2002365205A AU2002365205A1 AU 2002365205 A1 AU2002365205 A1 AU 2002365205A1 AU 2002365205 A AU2002365205 A AU 2002365205A AU 2002365205 A AU2002365205 A AU 2002365205A AU 2002365205 A1 AU2002365205 A1 AU 2002365205A1
Authority
AU
Australia
Prior art keywords
caprolactone
microparticles
adjuvant
poly
vaccine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002365205A
Inventor
Monserrat Barberan Pelegrin
Jose Blasco Martinez
Carlos Gamazo De La Rasilla
Maria Del Mar Goni Leza
Maria Jesus Grillo Dolset
Juan Manuel Irache Garreta
Clara Marin Alcala
Maria Isabel Murillo Martin
Judith Rene Gonzalez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instituto Cientifico y Tecnologico de Navarra SA
Original Assignee
Instituto Cientifico y Tecnologico de Navarra SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto Cientifico y Tecnologico de Navarra SA filed Critical Instituto Cientifico y Tecnologico de Navarra SA
Publication of AU2002365205A1 publication Critical patent/AU2002365205A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/098—Brucella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU2002365205A 2001-07-31 2002-07-23 Brucellosis vaccine composition comprising poly($g(e)-caprolactone) microparticles as an adjuvant Abandoned AU2002365205A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200101801 2001-07-31
ES200101801A ES2190350B1 (en) 2001-07-31 2001-07-31 COMPOSITION OF VACCINE AGAINST BRUCELOSIS THAT INCLUDES POLY MICROPARTICLES OF POLY (E-CAPROLACTONE) AS AN ASSISTANT.
PCT/ES2002/000367 WO2003059383A1 (en) 2001-07-31 2002-07-23 Brucellosis vaccine composition comprising poly($g(e)-caprolactone) microparticles as an adjuvant

Publications (1)

Publication Number Publication Date
AU2002365205A1 true AU2002365205A1 (en) 2003-07-30

Family

ID=8498592

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002365205A Abandoned AU2002365205A1 (en) 2001-07-31 2002-07-23 Brucellosis vaccine composition comprising poly($g(e)-caprolactone) microparticles as an adjuvant

Country Status (4)

Country Link
AR (1) AR034950A1 (en)
AU (1) AU2002365205A1 (en)
ES (1) ES2190350B1 (en)
WO (1) WO2003059383A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2327375B1 (en) 2007-11-14 2010-08-05 Universidad Del Pais Vasco USE OF MICROPARTICLES FOR USE AS VACCINES AND THE RELEASE OF BIOLOGICALLY ACTIVE MOLECULES.
AR073907A1 (en) * 2009-10-19 2010-12-09 Consejo Nac Invest Cient Tec ADJUSTER FOR VACCINES, WHICH INCLUDES AN UNLIPPED POLIPEPTIDE FROM THE EXTERNAL MEMBRANE (OMP) OF BACTERIA, VACCINES THAT UNDERSTAND AND USES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061062A1 (en) * 1998-05-29 1999-12-02 Massachusetts Institute Of Technology Cyclodextrin complexes

Also Published As

Publication number Publication date
WO2003059383A1 (en) 2003-07-24
AR034950A1 (en) 2004-03-24
ES2190350A1 (en) 2003-07-16
ES2190350B1 (en) 2005-01-01

Similar Documents

Publication Publication Date Title
IL188834A0 (en) Novel vaccine composition
GB0108364D0 (en) Vaccine composition
GB0103170D0 (en) Vaccine composition
AU2001297522A1 (en) Heat curable silicone compositions
AU2002229390A1 (en) Attenuated live vaccine
AU2002254558A1 (en) Novel vaccine
AU2002353417A1 (en) Adjuvanted antigenic meningococcal compositions
HUP0303942A3 (en) Novel vaccine composition
GB0126266D0 (en) Anthrax antigenic compositions
ZA200401211B (en) Antigenic compositions
AUPS222802A0 (en) Adjuvant composition
AU2002365205A1 (en) Brucellosis vaccine composition comprising poly($g(e)-caprolactone) microparticles as an adjuvant
AU2003273725A1 (en) Vaccine composition comprising interleukin-15 (il-15)
AU2002351234A1 (en) Antistatic polyester-polyethylene glycol compositions
AU2002236160A1 (en) Immunogenic complex comprising ribosomes
AU2002304165A1 (en) Polynucleotide vaccine
AU2002303093A1 (en) Mycobacterial vaccines
AU2002311405A1 (en) Vaccine composition
AU2002253048A1 (en) Novel vaccine
GB0108363D0 (en) Vaccine composition
GB0101138D0 (en) Vaccine composition
AUPR440001A0 (en) Vaccine
AU2002337263A1 (en) Anti-coronavirus vaccine
AU2002250006A1 (en) Fluoropolymer compositions
AU2002256201A1 (en) Fluoropolymer compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase